|
|
The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.
Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.
According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.
Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

